Compounded semaglutide formulated for sublingual use and prepared according to prescriber direction. Prescription required.
Semaglutide Sublingual is a compounded GLP-1 receptor agonist formulation designed for administration under the tongue, as prescribed by a licensed healthcare provider. HDRx prepares each prescription according to individualized specifications, including strength and dosing instructions.
Sublingual formulations may be considered when a prescriber determines an alternative dosage form is appropriate as part of a broader metabolic health plan.
Each preparation is compounded to order based on a valid prescription. Compounded medications are not FDA-approved and are prepared to address specific patient needs when commercially available options may not be suitable.
Patients should consult their healthcare provider to determine whether this formulation aligns with their individual health goals.
